Impact of Depressive Symptoms on All-Cause Mortality in Patients with Congestive Heart Failure After Cardiac Resynchronization Therapy

Purpose: to assess the association between depression and all-cause mortality in patients with congestive heart failure (CHF) after cardiac resynchronization therapy (CRT).

Materials and Methods. We enrolled in this study 156 patients (mean age 55.3±9.6 years) with CHF and implanted devices for CRT. Mean duration of follow-up was 51.6±33.4 months. The Beck Depression Inventory (BDI) was used to evaluate depressive symptoms (DS); DS were considered absent for a score 0–9, mild to moderate – 10–18, severe – ≥19. For assessment of association of DS and mortality we used multivariate Cox proportional hazards regression model with estimation of hazard ratios (HR) with 95 % confidence intervals (95 %CI).

Results. Average Beck Depression Inventory score was 12.4±8.3. In 66 patients (42.3 %) there were no DS, 57 patients (36.5 %) had mild, and 33 (21.2 %) – severe DS. These groups did not differ by main clinical-functional and laboratory indicators. Among individuals without DS prevailed men (90.9 vs. 69.7 % among those with severe DS, p=0.007). Hypercholesterolemia was more frequent in patients with DS (63.3 vs. 43.9 % in patients without DS, p=0.02). During follow-up 33 patients died (21.2 %). Adjusted HR of death from all-causes for DS score as continuous parameter was 1.05, 95 % CI 1.01–1.09, p=0.02. Patients without DS were used as reference (HR=1.0) in analysis of categorical indicator. HR was 1.08, 95 % CI 0.46–2.54, p=0.9 in patients with mild, and 2.92, 95 % CI 1.17–7.32, p=0.02 – with severe DS.

Conclusion: DS were associated with gender and hypercholesterolemia. Severe DS were independently associated with all-cause mortality in patients with CHF and implanted CRT devices.

1. Oganov R. G., Shalnova S. A., Kalinina A. M. Cardiovascular disease prevention: manual. Moscow: GEOTAR-Media 2009;216р. Russian (Оганов Р.Г., Шальнова С.А., Калинина А.М. Профилактика сердечно-сосудистых заболеваний. Москва: GEOTARMedia 2009; 216 c.)

2. Piepoli M. F., Hoes A. W., Agewall S. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Heart J 2016;37:2315–2381. DOI: 10.1093/eurheartj/ehw106.

3. Lichtman J. H, Bigger J. T., Blumenthal J. A. et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008;118(17):1768–75. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.190769.

4. Chazov E. I., Oganov R. G., Pogosova G. V. et al. ClinicoEpidemiolOgical RrOgram of the Study of DeoRession in CarDiological PractIce iN Patients With Arterial Hypertension and Ischemic HearT DiseAse (COORDINATA). Kardiologiia 2007;3:28–37. Russian (Чазов Е. И., Оганов Р. Г., Погосова Г. В. и др. Клинико-эпидемиологическая программа изучения депрессии в кардиологической практике: у больных артериальной гипертонией и ишемической болезнью сердца (КООРДИНАТА): результаты многоцентрового исследования. Кардиология 2007;3:28–37).

5. Pedersen S. S., Denollet J., Daemen J. et al. Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. J Psychosom Res 2007;62(4):455–461. DOI: http://dx.doi.org/10.1016/j.jpsychores.2006.12.018.

6. Ponikowski P., Voors A. A., Anker S. D. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart J 2016; 37: 2129–2200. DOI: 10.1093/eurheartj/ehw128.

7. Oganov R. G., Pogosova G. V., Shalnova S. A., Deev A. D. Depressive Discorders in General Medical Practice in KOMPAS Study: Outlook of a Cardiologist. Kardiologiia 2005;8:37–43. Russian (Оганов Р. Г., Погосова Г. В., Шальнова С. А., Деев А. Д. Депрессивные расстройства в общемедицинской практике по данным исследования КОМПАС: взгляд кардиолога. Кардиология 2005;8:37–43).

8. Rutledge T., Reis V. A., Linke S. E. et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006;48(8):1527–1537. DOI: 10.1016/j.jacc.2006.06.055.

9. Brignole M., Auricchio A., Baron-Esquivias G. et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. European Heart J 2013;34:2281–2329. DOI: 10.1093/eurheartj/eht150.

10. Knackstedt C., Arndt M., Mischke K. et al. Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy. Heart Vessels 2014;29(3):364–74. DOI: 10.1007/s00380-013-0372-8.

11. Ploux S., Verdoux H., Whinnett Z. et al. Depression and severe heart failure: benefits of cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2012;23(6):631–636. DOI: 10.1111/j.1540-8167.2011.02258.x

12. Shalaby A. A., Brumberg G. E., Pointer L. et al. Depression and outcome among veterans with implantable cardioverter defibrillators with or without cardiac resynchronization therapy capability. Pacing Clin Electrophysiol 2014;37(8):994–1001. DOI:10.1111/pace.12361.

13. Shalaby A., Brumberg G., El-Saed A., Saba S. Mood disorders and outcome in patients receiving cardiac resynchronization therapy. Pacing Clin Electrophysiol 2012;35(3):294–301. DOI: 10.1111/j.1540-8159.2011.03304.x

14. Beck A. T., Ward C. H., Mendelson M. et al. An Inventory for Measuring Depression. Arch Gen Psychiatry 1961;4(6):561–571. DOI: 10.1001/archpsyc.1961.01710120031004.

15. Tarabrina N.V. Workshop on the psychology of post-traumatic stress. SPb.: Piter 2001; 272p. Russian (Тарабрина Н.В. Теоретические основы посттравматического стресса. СПб: Питер 2001;272с.).

16. Ivchenko G. I., Medvedev Ju. I. Mathematical statistics. Librokom 2014; 352p. Russian (Ивченко Г. И., Медведев Ю. И. Математическая статистика. Либроком 2014; 352с.).

17. Silverstein B., Edwards T., Gamma A. et al. The role played by depression associated with somatic symptomatology in accounting for the gender difference in the prevalence of depression. Soc Psychiatry Psychiatr Epidemiol 2013;48(2):257–263. DOI: 10.1007/s00127-012- 0540-7.

18. Tyuvina N. A., Balabanova V. V., Voronina E. O. Gender features of depressive disorders in women. Neurology, Neuropsychiatry, Psychosomatics 2015;7(2):75–79. Russian (Тювина Н.А., Балабанова В. В., Воронина Е. О. Гендерные особенности депрессивных расстройств у женщин. Неврология, нейропсихиатрия, психосоматика 2015;7(2):75–79). DOI: 10.14412/2074-2711-2015-2-75-79.

19. Tyuvina N. A. The differential diagnosis and treatment of depressive disorders in menopausal women. Neurology, Neuropsychiatry, Psychosomatics 2011;3(1):66–71. Russian (Тювина Н. А. Дифференциальная диагностика и лечение депрессивных расстройств у женщин в период климактерия. Неврология, нейропсихиатрия, психосоматика 2011;3(1):66–71). DOI: http://dx.doi.org/10.14412/2074-2711-2011-137.

20. Smetnik V. P., Kulakov V. I. Manual on menopause. Moscow: Medicinskoe informacionnoe agentstvo 2001; 685p. Russian (Сметник В. П., Кулаков В. И. Руководство по менопаузе. М.: Медицинское информационное агентство 2001; 685с.).

21. Nakao M., Yano E. Relationship between major depression and high serum cholesterol in Japanese men. Tohoku J Exp Med 2004;204(4):273-87. PMID: 15572853

22. Marazziti D., Rutigliano G., Baroni S. et al. Metabolic syndrome and major depression. CNS Spectr 2014;19(4):293-304. DOI:10.1017/S1092852913000667

23. Chuang C. S., Yang T. Y., Muo C. H. et al. Hyperlipidemia, statin use and the risk of developing depression: a nationwide retrospective cohort study. Gen Hosp Psychiatry 2014;36(5):497–501. DOI:10.1016/j.genhosppsych.2014.05.008.

24. DiMatteo M. R., Lepper H. S., Croghan T. W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160(14):2101–2107. PMID: 10904452

25. Sokoreli I., de Vries J. J., Riistama J. M. et al. Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure. Int J Cardiol 2016;220:202– 207. DOI: http://dx.doi.org/10.1016/j.ijcard.2016.06.068.

26. Watkins L. L., Koch G. G., Sherwood A. et al. Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. J Am Heart Assoc 2013;2:e000068. DOI:10.1161/JAHA.112.000068.

27. Konrad M., Jacob L., Rapp M. A., Kostev K. Depression risk in patients with coronary heart disease in Germany. World J Cardiol 2016;8(9):547–552. DOI:10.4330/wjc.v8.i9.547.

28. Kuznetsov V., Soldatova A., Enina T., Petelina T. Natriuretic peptide and inflammation mediators in patients with different responses to cardiac resynchronization therapy. Russian Heart Failure Journal 2015;16(2):88–92. Russian (Кузнецов В. А., Солдатова А. М., Енина Т. Н., Петелина Т. И. Натрийуретический пептид и медиаторы воспаления у пациентов с различным ответом на сердечную ресинхронизирующую терапию. Журнал Сердечная Недостаточность 2015;16(2):88–92).

29. Osipova O., Suyazova S., Vlasenko M., Godlevskaya M. Cytokines in development and advance of chronic heart failure. Journal of New Medical Technologies 2012;2:322–327. Russian (Осипова О. А., Суязова С. Б., Власенко М. А., Годлевская О. М. Цитокины в развитии и прогрессировании хронической сердечной недостаточности. Вестник новых медицинских технологий 2012;XIX(2):322–327).

30. Howren M. B., Lamkin D. M., Suls J. Associations of Depression with C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis. Psychosomatic Medicine 2009;71(2):171–186. DOI:10.1097/PSY.0b013e3181907c1b.

31. Torre-Amione G., Kapadia S., Benedict C. et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 1996;27(5):1201–1206. DOI: 10.1016/0735-1097(95)00589-7.

32. Nasonov E. L., Samsonov M. Ju., Belenkov Ju. N., Fuks D. Immunopathology of congestive heart failure: the role of cytokines. Kardiologiia 1999;3:66–73. Russian (Насонов Е.Л., Самсонов М. Ю., Беленков Ю. Н., Фукс Д. Иммунопатология застойной сердечной недостаточности: роль цитокинов. Кардиология 1999;3: 66–73).

33. Berezikova E. N., Shilov S. N., Efremov A. V. et al. The role of cytokine aggression in the develorment of chronic heart failure. Kubanskij nauchnyj medicinskij vestnik 2011;4(127):29–31. Russian (Березикова Е. Н., Шилов С. Н., Ефремов А. В. и др. Роль цитокиновой агрессии в развитии хронической сердечной недостаточности. Кубанский научный медицинский вестник 2011;4(127):29–31).